人工智能在造血干细胞移植护理和并发症管理中的应用
Acta haematologica
|August 5, 2025
概括
人工智能 (AI) 正在通过改善供体选择和减少并发症来改变全源造血干细胞移植 (alloHCT). 对于这些强大的新工具的广泛临床整合,需要进一步验证.
科学领域:
- 血液学 血液学 血液学
- 医疗信息学 医疗信息学
- 计算生物学 计算生物学
背景情况:
- 全基性造血干细胞移植 (alloHCT) 已发展成为一种标准治疗方法,在全球范围内越来越多地应用.
- 减少强度的方案和增强的支持性护理改善了allHCT的安全性,并扩大了患者的资格.
- 人工智能 (AI) 和大数据分析方面的进步正在为血液学创造新的机会.
研究的目的:
- 审查AI在血液学中的当前应用,特别关注alloHCT.
- 讨论管理和预防移植相关并发症的新兴人工智能工具.
- 突出人工智能的潜力,提高诊断,治疗和患者监测alloHCT.
主要方法:
- 关于人工智能在血液学和 alloHCT 的应用现有文献的综述.
- 对用于移植相关并发症管理的新兴人工智能工具的分析.
- 讨论大数据集成及其在医生决策支持中的作用.
主要成果:
- 人工智能工具在诸如供体选择,减少非复发死亡率,感染管理和移植对宿主疾病控制等领域表现有前途.
- 大多数人工智能模型目前都是实验性的,基于单中心研究.
- 跨医疗保健网络的标准化数据集成对于AI实施至关重要.
结论:
- 人工智能具有显著的潜力,可以进一步提高alloHCT的安全性和有效性.
- 持续的验证和医疗器械研究对于AI在allHCT中的临床整合至关重要.
- 人工智能是医疗实践中正在进行的数字化转型的关键组成部分.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
01:21Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
01:22Bone Marrow Sampling and Transplants
500
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
500
01:19Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
01:21Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K